Clinical trial
HSIL/ACIS/Early Cervical Cancer: What Are The Current Causative HPV Subtypes in the Era of HPV Vaccination?
NCT02937155 is registered in ClinicalTrials.gov with Sunnybrook Health Sciences Centre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HSIL/ACIS/Early Cervical Cancer: What Are The Current Causative HPV Subtypes in the Era of HPV Vaccination?
- Lead sponsor
- Sunnybrook Health Sciences Centre
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 30, 2016
- Completion date
- September 30, 2024
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adenocarcinoma in situ, early cervical cancer, hsil, high-grade squamous intraepithelial lesions